Clonazepam Tablet shortage
Current 40 presentations · 6 manufacturers · first FDA posting 2023-03-10 · last update 2026-10-15
Manufacturers: Accord Healthcare Inc., Aurobindo Pharma USA, Cheplapharm Arzneimittel GmbH, Prinston Pharmaceutical, Inc., Rubicon Research Private Limited, Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Other
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Clonazepam, Tablet, .5 mg (NDC 16729-136-00) | Accord Healthcare Inc. | Current Available |
— | Posted 03/10/2023 Updated 10/03/2026 | |
| Clonazepam, Tablet, .5 mg (NDC 16729-136-16) | Accord Healthcare Inc. | Current Available |
— | Posted 03/10/2023 Updated 10/03/2026 | |
| Clonazepam, Tablet, 1 mg (NDC 16729-137-00) | Accord Healthcare Inc. | Current Available |
— | Posted 03/10/2023 Updated 10/03/2026 | |
| Clonazepam, Tablet, 1 mg (NDC 16729-137-16) | Accord Healthcare Inc. | Current Available |
— | Posted 03/10/2023 Updated 10/03/2026 | |
| Clonazepam, Tablet, 2 mg (NDC 16729-138-00) | Accord Healthcare Inc. | Current Available |
— | Posted 03/10/2023 Updated 10/03/2026 | |
| Clonazepam, Tablet, 2 mg (NDC 16729-138-16) | Accord Healthcare Inc. | Current Available |
— | Posted 03/10/2023 Updated 10/03/2026 | |
| Clonazepam, Tablet, .5 mg (NDC 59651-722-01) | Aurobindo Pharma USA | Current Available |
— | Posted 03/10/2023 Updated 10/02/2026 | |
| Clonazepam, Tablet, .5 mg (NDC 59651-722-99) | Aurobindo Pharma USA | Current Available |
— | Posted 03/10/2023 Updated 10/02/2026 | |
| Clonazepam, Tablet, 1 mg (NDC 59651-723-01) | Aurobindo Pharma USA | Current Available |
— | Posted 03/10/2023 Updated 10/02/2026 | |
| Clonazepam, Tablet, 1 mg (NDC 59651-723-99) | Aurobindo Pharma USA | Current Available |
— | Posted 03/10/2023 Updated 10/02/2026 | |
| Clonazepam, Tablet, 2 mg (NDC 59651-724-01) | Aurobindo Pharma USA | Current Available |
— | Posted 03/10/2023 Updated 10/02/2026 | |
| Clonazepam, Tablet, 2 mg (NDC 59651-724-05) | Aurobindo Pharma USA | Current Available |
— | Posted 03/10/2023 Updated 10/02/2026 | |
| Klonopin, Tablet, .5 mg (NDC 61269-605-10) | Cheplapharm Arzneimittel GmbH | Current Available |
— | Marketed by H2-Pharma | Posted 03/10/2023 Updated 10/02/2026 |
| Klonopin, Tablet, 1 mg (NDC 61269-610-10) | Cheplapharm Arzneimittel GmbH | Current Available |
— | Marketed by H2-Pharma | Posted 03/10/2023 Updated 10/02/2026 |
| Klonopin, Tablet, 2 mg (NDC 61269-620-10) | Cheplapharm Arzneimittel GmbH | Current Unavailable |
Other | Estimated Duration: February 2027. Shortage per Manufacturer: Manufacturing Delay. Marketed by H2-Pharma. | Posted 03/10/2023 Updated 10/02/2026 |
| Clonazepam, Tablet, .5 mg (NDC 43547-406-10) | Prinston Pharmaceutical, Inc. | Current Available |
— | Marketed by Solco Healthcare | Posted 03/10/2023 Updated 09/02/2026 |
| Clonazepam, Tablet, .5 mg (NDC 43547-406-11) | Prinston Pharmaceutical, Inc. | Current Available |
— | Marketed by Solco Healthcare | Posted 03/10/2023 Updated 09/02/2026 |
| Clonazepam, Tablet, .5 mg (NDC 43547-406-50) | Prinston Pharmaceutical, Inc. | Current Available |
— | Marketed by Solco Healthcare | Posted 03/10/2023 Updated 09/02/2026 |
| Clonazepam, Tablet, 1 mg (NDC 43547-407-10) | Prinston Pharmaceutical, Inc. | Current Available |
— | Marketed by Solco Healthcare | Posted 03/10/2023 Updated 09/02/2026 |
| Clonazepam, Tablet, 1 mg (NDC 43547-407-11) | Prinston Pharmaceutical, Inc. | Current Available |
— | Marketed by Solco Healthcare | Posted 03/10/2023 Updated 09/02/2026 |
| Clonazepam, Tablet, 1 mg (NDC 43547-407-50) | Prinston Pharmaceutical, Inc. | Current Available |
— | Marketed by Solco Healthcare | Posted 03/10/2023 Updated 09/02/2026 |
| Clonazepam, Tablet, 2 mg (NDC 43547-408-10) | Prinston Pharmaceutical, Inc. | Current Available |
— | Marketed by Solco Healthcare | Posted 03/10/2023 Updated 09/02/2026 |
| Clonazepam, Tablet, 2 mg (NDC 43547-408-50) | Prinston Pharmaceutical, Inc. | Current Available |
— | Marketed by Solco Healthcare | Posted 03/10/2023 Updated 09/02/2026 |
| Clonazepam, Tablet, .5 mg (NDC 72888-152-00) | Rubicon Research Private Limited | Current Available |
— | Marketed by Advagen Pharma Ltd. | Posted 03/10/2023 Updated 06/01/2026 |
| Clonazepam, Tablet, .5 mg (NDC 72888-152-01) | Rubicon Research Private Limited | Current Available |
— | Marketed by Advagen Pharma Ltd. | Posted 03/10/2023 Updated 06/01/2026 |
| Clonazepam, Tablet, .5 mg (NDC 72888-152-05) | Rubicon Research Private Limited | Current Available |
— | Marketed by Advagen Pharma Ltd. | Posted 03/10/2023 Updated 06/01/2026 |
| Clonazepam, Tablet, .5 mg (NDC 72888-152-30) | Rubicon Research Private Limited | Current Available |
— | Marketed by Advagen Pharma Ltd. | Posted 03/10/2023 Updated 06/01/2026 |
| Clonazepam, Tablet, 1 mg (NDC 72888-153-00) | Rubicon Research Private Limited | Current Available |
— | Marketed by Advagen Pharma Ltd. | Posted 03/10/2023 Updated 06/01/2026 |
| Clonazepam, Tablet, 1 mg (NDC 72888-153-01) | Rubicon Research Private Limited | Current Available |
— | Marketed by Advagen Pharma Ltd. | Posted 03/27/2023 Updated 06/01/2026 |
| Clonazepam, Tablet, 1 mg (NDC 72888-153-05) | Rubicon Research Private Limited | Current Available |
— | Marketed by Advagen Pharma Ltd. | Posted 03/10/2023 Updated 06/01/2026 |
| Clonazepam, Tablet, 1 mg (NDC 72888-153-30) | Rubicon Research Private Limited | Current Available |
— | Marketed by Advagen Pharma Ltd. | Posted 03/10/2023 Updated 06/01/2026 |
| Clonazepam, Tablet, 2 mg (NDC 72888-154-01) | Rubicon Research Private Limited | Current Available |
— | Marketed by Advagen Pharma Ltd. | Posted 03/10/2023 Updated 06/01/2026 |
| Clonazepam, Tablet, 2 mg (NDC 72888-154-05) | Rubicon Research Private Limited | Current Available |
— | Marketed by Advagen Pharma Ltd. | Posted 03/10/2023 Updated 06/01/2026 |
| Clonazepam, Tablet, 2 mg (NDC 72888-154-30) | Rubicon Research Private Limited | Current Available |
— | Marketed by Advagen Pharma Ltd. | Posted 03/10/2023 Updated 06/01/2026 |
| Clonazepam, Tablet, .5 mg (NDC 0093-0832-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted 03/10/2023 Updated 10/15/2026 | |
| Clonazepam, Tablet, .5 mg (NDC 0093-0832-05) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted 03/10/2023 Updated 10/15/2026 | |
| Clonazepam, Tablet, 1 mg (NDC 0093-3212-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted 03/10/2023 Updated 10/15/2026 | |
| Clonazepam, Tablet, 1 mg (NDC 0093-3212-05) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted 03/10/2023 Updated 10/15/2026 | |
| Clonazepam, Tablet, 2 mg (NDC 0093-3213-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted 03/10/2023 Updated 10/01/2026 | |
| Clonazepam, Tablet, 2 mg (NDC 0093-3213-05) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted 03/10/2023 Updated 10/15/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)